Medium materiality6/10
Medline price target lowered to $42 from $45 at Bairdq
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Baird lowers MDLN target to $42 from $45.
- Target downgrade; price ~ $35.30
Key facts
- 01
Target: $42
- 02
Posted price: $35.3
- 03
Analyst firm: Robert W. Baird
- 04
Analyst: Eric Coldwell
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.